Slide 1: Q4 & FY 2021 Results
Q4 & FY 2021 Results Milan, March 3°49, 2022 amplifon
Slide 2: Disclaimer
Disclaimer The following applies to this document, the oral presentation of the information in this document by Amplifon S.p.A. (the “Company”) or any person on behalf of the Company, and any question-and-answer session that follows the oral presentation (collectively, the “Information”). In accessi
Slide 3: 2021: a truly outstanding year
202I: a truly outstanding year Revenues ~ >. putt +70% vs 2019 Flat vs very strong 2020 © Amplifon S.p.A March 3rd, 2022 EBITDA recurring : 483me : Margin at 24.8% “pps vs 2019 x Leverage 68x — NFP at 87Imé After >600 m€ investments Net Profit recurring [75me +50% vs 2019 26 eurojeents dividend per
Slide 4: Q4 2021 Financial highlights
Q4 202I Financial highlights A strong finish of the year despite December peak in Covid-contagions and very challenging comparison basis Data in €m Q4 2021 Q42020 Q4 2019 A 21/20 A21/19 REVENUES 568.2 499.3 488.6 +13.8% +16.3% Organic growth 45.4% +8.4% Acquisitions +6.8% +8.7% FX 41.6% -0.8% EBITDA
Slide 5: ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 6: ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ Δ 21/20 Δ
▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪
Slide 7: ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Δ
▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 8: ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ Δ 21/20
▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ Δ 21/20 Δ 21/19 ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 9: Q4 2021 Financial results
Q4 2021 Financial results Excellent results across the board with impressive operating leverage leading to a Net Profit recurring of ~€70 million, ~+47% vs Q4 2019 Data in €m Q4 2021 Q4 2020 Q4 2019 A Rec A Rec (unless specified) Recurring Reported Recurring Reported Recurring Reported 21/20 21/19 R
Slide 10: FY 2021 Financial results
FY 2021 Financial results Another record year in all P&L items with a strong step-up in Net Profit recurring at ~€175 million, up ~+50% vs 2019 and over +80% vs 2020 Data in €m FY 2021 FY 2020 FY 2019 A Rec A Rec (unless specified) Recurring Reported Recurring Reported Recurring Reported 21/20 21/19
Slide 11: FY 2021 Financial results
FY 2021 Financial results Operating Cash Flow & Free Cash Flow up, respectively, over +50% and +70% vs 2019 Data in €m FY 2021! FY 20207 FY 2019° Operating cash flow before repayment of lease liabilities 461.2 386.9 319.8 Repayment of lease liabilities (95.2) (72.8) (81.0) Operating cash flow 365.9
Slide 12: FY 2021 Financial results
FY 2021 Financial results Leverage at I.68x unchanged vs year-end 2020 after strong investments, transformational M&A and robust shareholders’ return Data in €m 31/12/2021 31/12/2020 Cash (268.6) (545.0) Short-term debt 116.0 75.4 Medium/long-term debt 1,023.8 1103.3 Net financial debt 871.2 633.7 L
Slide 13: Strong commitment for a more inclusive and sustainable future
Strong commitment for a more inclusive and sustainable future Delivering on our sustainability strategy Product & service stewardship ~€200 million savings generated for customers & prospects thanks to free hearing tests >170 million people reached by awareness-raising campaigns on hearing well-bein
Slide 14: End-to-end from design to MVP development
End-to-end from design Patented digital products for Bocconi Chair in Customer >50 digital talents to MVP development customers and audiologist Science >€150m cumulated investments (ampli-care: ECC, Otopad, etc.) in 22-24
Slide 15: 2022 Outlook
2022 Outlook Highly confident in another excellent year as well as in our mid-term targets = In 2022 we expect the hearing care market to grow 4-5%, supported by a positive contribution from pent-up demand which will more than offset the challenging comparison base in the French market due to the 20
Slide 16: Roadshows & conferences
Roadshows & conferences post FY2021I Results Upcoming events = 4 March: Milan (Equita) = 22 April: Shareholders’ Meeting = 8 March: Paris (Exane) = 3 May: QI 2022 Results = 9 March: London (Goldman Sachs) = 28 July: Hl 2022 Results = 10-11 March: Zurich & Geneva (Oddo BHF) = 26 October: Q3 2022 Resu